XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Retained earnings
Accumulated other comprehensive income (loss)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2021   20,085,336    
Beginning balance at Dec. 31, 2021 $ 715,339 $ 249,856 $ 444,343 $ 21,140
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 58,039   58,039  
Share-based compensation expense 3,239 $ 3,239    
Common stock issued - Stock grants (in shares)   130,546    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (127,071)     (127,071)
Dividends declared on common stock (20,435)   (20,435)  
Common stock repurchased (in shares)   (1,498,325)    
Common stock repurchased (76,322) $ (27,370) (48,952)  
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2022   18,717,557    
Ending balance at Sep. 30, 2022 552,789 $ 225,725 432,995 (105,931)
Common stock shares outstanding, beginning balance (in shares) at Jun. 30, 2022   18,712,789    
Beginning balance at Jun. 30, 2022 580,767 $ 224,776 419,254 (63,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 20,367   20,367  
Share-based compensation expense 942 $ 942    
Common stock issued - Stock grants (in shares)   4,328    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (42,668)     (42,668)
Dividends declared on common stock (6,638)   (6,638)  
Common stock repurchased (in shares)   (440)    
Common stock repurchased 19 $ 7 12  
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2022   18,717,557    
Ending balance at Sep. 30, 2022 $ 552,789 $ 225,725 432,995 (105,931)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2022 18,730,380 18,730,380    
Beginning balance at Dec. 31, 2022 $ 562,147 $ 226,592 435,085 (99,530)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (24,089)   (24,089)  
Share-based compensation expense 2,696 $ 2,696    
Common stock issued - Stock grants (in shares)   76,744    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (27,488)     (27,488)
Dividends declared on common stock (10,463)   (10,463)  
Common stock repurchased (in shares)   (13,094)    
Common stock repurchased $ (316) $ (316)    
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2023 18,794,030 18,794,030    
Ending balance at Sep. 30, 2023 $ 502,487 $ 228,972 400,533 (127,018)
Common stock shares outstanding, beginning balance (in shares) at Jun. 30, 2023   18,776,597    
Beginning balance at Jun. 30, 2023 527,623 $ 228,260 400,132 (100,769)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 2,295   2,295  
Share-based compensation expense 712 $ 712    
Common stock issued - Stock grants (in shares)   17,433    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (26,249)     (26,249)
Dividends declared on common stock (1,894)   (1,894)  
Common stock repurchased (in shares)   0    
Common stock repurchased $ 0      
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2023 18,794,030 18,794,030    
Ending balance at Sep. 30, 2023 $ 502,487 $ 228,972 $ 400,533 $ (127,018)